Clinical Trial Update: NIraparib and Quality of LifE is a Longitudinal Study Evaluating in Real Life the Tolerability of Niraparib. [Phase 4]

View source ↗

Summary

Phase 4 real-world study assessing tolerability and quality of life for niraparib in ovarian cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Niraparib (Niraparib)

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer | Phase 4 | Status: COMPLETED